Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
St. Jude Children’s Research Hospital Inc, Medical Devices Deals, 2011 to YTD 2017 11
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
NanoViricides Enters into Agreement with St. Jude Children’s Research Hospital 14
Cesca Therapeutics Enters into Agreement with St. Jude Children’s Research Hospital 15
Eisai Enters into Research Agreement with St. Jude Children’s Research Hospital and Medicines For Malaria Venture to Develop SJ733 16
Retrophin Enters Into Research Agreement With St. Jude Children’s Research Hospital 17
Licensing Agreements 18
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 18
Juno Therapeutics Enters into Licensing Agreement with St. Jude Children’s Research Hospital 19
Ultragenyx Pharmaceutical Enters Into Licensing Agreement with St. Jude Children’s Research Hospital 20
BioMarin Pharma Enters Into Licensing Agreement With University College London And St. Jude Children’s Research Hospital For Hemophilia A Gene Therapy Program 21
St. Jude Children’s Research Hospital Inc – Key Competitors 23
St. Jude Children’s Research Hospital Inc – Key Employees 24
St. Jude Children’s Research Hospital Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Corporate Communications 26
Jan 30, 2017: Stephen Gottschalk, M.D., has been named chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital 26
Mar 24, 2016: Souplantation, Sweet Tomatoes Shatter Goal, Raise $300,000 for St. Jude Children’s Research Hospital to Fight Childhood Cancer, Other Life-Threatening Diseases 27
Government and Public Interest 28
May 03, 2017: St. Jude maps genome organization to link retinal development and retinoblastoma 28
Apr 11, 2017: Success of sensory cell regeneration raises hope for hearing restoration 30
Sep 30, 2016: NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease 32
Aug 15, 2016: CRISPR gene editing reveals new therapeutic approach for sickle cell disease 33
Mar 01, 2016: Protein revealed as glue that holds biomolecules within the nucleolus 34
Feb 26, 2016: New brain cancer types emerge based on molecular characteristics 36
Feb 15, 2016: Discovery lays the foundation to expand personalized chemotherapy for leukemia patients 37
Feb 15, 2016: Newly identified genes impact how transplanted stem cells give rise to blood cells 39
Feb 08, 2016: Scientists discover a unique mechanism for a high-risk leukemia 40
Feb 01, 2016: Study finds significant cognitive impairment in adult survivors of childhood brain tumors 42
Jan 29, 2016: Drug counters effects of excessive inflammation arising from immune disorder 44
Jan 28, 2016: Mining the epigenome to identify likely origins of childhood brain tumor subtype 45
Jan 27, 2016: Researchers mine the epigenome to identify likely origins of childhood brain tumor subtype 47
Jan 25, 2016: Discovery reveals how protective immune cells protect themselves 49
Jan 13, 2016: New drug target identified for X-linked lymphoproliferative disease 50
Jan 11, 2016: Scientists identify protein interaction that defines an aggressive brain tumor subtype 51
Product News 53
Mar 14, 2016: St. Jude research will guide development of new anti-influenza drugs 53
Other Significant Developments 55
Aug 30, 2017: St. Jude unveils powerful resource to advance treatment of pediatric solid tumors 55
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Key Facts 2
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
St. Jude Children’s Research Hospital Inc, Deals By Therapy Area, 2011 to YTD 2017 9
St. Jude Children’s Research Hospital Inc, Medical Devices Deals, 2011 to YTD 2017 11
St. Jude Children’s Research Hospital Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 13
NanoViricides Enters into Agreement with St. Jude Children's Research Hospital 14
Cesca Therapeutics Enters into Agreement with St. Jude Children's Research Hospital 15
Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 16
Retrophin Enters Into Research Agreement With St. Jude Children's Research Hospital 17
Calimmune Enters into Licensing Agreement with St. Jude Children’s Research Hospital 18
Juno Therapeutics Enters into Licensing Agreement with St. Jude Children’s Research Hospital 19
Ultragenyx Pharmaceutical Enters Into Licensing Agreement with St. Jude Children’s Research Hospital 20
BioMarin Pharma Enters Into Licensing Agreement With University College London And St. Jude Children's Research Hospital For Hemophilia A Gene Therapy Program 21
St. Jude Children’s Research Hospital Inc, Key Competitors 23
St. Jude Children’s Research Hospital Inc, Key Employees 24